Apostrophe, a telehealth skin care brand, will cease operations under the Hims & Hers umbrella after nearly four years. Founded in 2012 as YoDerm, Apostrophe was acquired for over $130 million in 2021. The decision to close Apostrophe aims to simplify dermatology services and enhance customer experience. Its website now indicates a discontinuation and encourages customers to transition to Hims or Hers for similar services. Hims & Hers has also seen a surge in stock performance attributed to new weight-loss medication sales amidst a nationwide shortage of alternatives.
Hims & Hers spokesperson Farshad Shadloo stated, 'After careful consideration, we are discontinuing Apostrophe to simplify our dermatology products and operations into one seamless experience for our customers.'
Apostrophe's website currently states, 'Apostrophe is being discontinued and all current subscriptions will be canceled as of March 7th, 2025.' Customers need to seek alternatives with Hims or Hers.
Collection
[
|
...
]